Vasopressin receptors influencing the secretion of ACTH by the rat adenohypophysis.

  title={Vasopressin receptors influencing the secretion of ACTH by the rat adenohypophysis.},
  author={Julia C. Buckingham},
  journal={The Journal of endocrinology},
  volume={113 3},
  • J. Buckingham
  • Published 1 June 1987
  • Biology, Medicine
  • The Journal of endocrinology
The effects of selective agonists and antagonists of type 1 (V1) and type 2 (V2) vasopressin receptors on the secretion of ACTH in vitro by segments of adenohypophysial tissue and in vivo in rats pretreated with pentobarbitone and chlorpromazine were studied in the presence and absence of the 41 amino acid-containing peptide, corticotrophin-releasing factor-41 (CRF-41). The non-selective vasopressin receptor agonist, arginine vasopressin (AVP) and the V1-receptor agonist, felypressin caused… 
Involvement of vasopressin and corticotropin-releasing hormone in VIP- and PHI-induced secretion of ACTH and corticosterone
The hypothesis that the activation of the hypothalamic-pituitary-adrenal (HPA) axis by VIP and PHI is mediated through the release of endogenous CRH is supported, possibly by enhancing the activity of CRH in a synergistic manner.
Corticotrophin-releasing activity of desmopressin in Cushing's disease: lack of correlation between in vivo and in vitro responsiveness.
The marked stimulatory effect of DDAVP observed in patients with Cushing's disease appears to be mainly dependent on an extrapituitary action, possibly the inhibition of a corticotrophin release-inhibitory factor.
1-desamino-8-D-arginine vasopressin (DDAVP) as an agonist on V1b vasopressin receptor.
DDAVP acts as an agonist on V1b receptor, as it does on V2 receptor, and will help to identify as yet unknown vasopressin receptors through which DDAVP cause the accumulation of intracellular Ca2+ in other tissues.
Vasopressin receptor expression and mutation analysis in corticotropin-secreting tumors.
It is speculated that the response to the desmopressin test observed in patients with Cushing's disease may be due to abnormal expression of V3R or V2R in ACTH-secreting tumors.
Vasopressin pressor receptor-mediated activation of HPA axis by acute ethanol stress in rats.
  • F. László, C. Varga, +6 authors G. Makara
  • Chemistry, Medicine
    American journal of physiology. Regulatory, integrative and comparative physiology
  • 2001
The hypothesis that stress-induced AVP may not only act directly on the ACTH producing anterior pituitary cells but also indirectly at the hypothalamic level via the synthesis and release of CRH is supported.
Arginine vasopressin inhibits nitric oxide synthesis in cytokine-stimulated vascular smooth muscle cells.
Results indicate that AVP inhibits IL-1 beta-induced iNOS expression in VSMCs through the V1a receptor, which is mediated at least partially via activation of protein kinase C.
Cardiovascular effects of felypressin.
It was concluded that FEL depends on V1 receptors to induce pressor and bradycardic effects, and that it produces a high relationship betweenBradycardia and mean arterial pressure variation depending on area postrema and central V1 receptor.
Vasopressin and adrenalectomy-induced sensitivity to morphine.
It is proposed that vasopressin is a critical neuropeptide factor involved in the adrenalectomy-induced hypersensitivity to morphine antinociception.
Effect of AVP on susceptibility of ovine pituitary cells to a cytotoxic analogue of CRF.
Data suggest that, if AVP induces erstwhile non-CRF target cells to become CRF targets, then these induced cells are not themselves initially AVP target corticotrophs.
The role of vasopressin in diabetes mellitus-induced hypothalamo-pituitary-adrenal axis activation: Studies in Brattleboro rats
The data suggest that AVP does not play a crucial role in HPA axis regulation during DM-induced chronic stress, and in contrast, the role of AVP seems to be more important during acute stress, however, it is restricted to the ACTH regulation.